z-logo
open-access-imgOpen Access
MiR-15b Targets Cyclin D1 to Regulate Proliferation and Apoptosis in Glioma Cells
Author(s) -
Guan Sun,
Lei Shi,
Shushan Yan,
Zhengqiang Wan,
Nan Jiang,
Linshan Fu,
Min Li,
Jun Guo
Publication year - 2014
Publication title -
biomed research international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 126
eISSN - 2314-6141
pISSN - 2314-6133
DOI - 10.1155/2014/687826
Subject(s) - cyclin d1 , glioma , cancer research , cell cycle , cyclin d , cell growth , apoptosis , transfection , cell cycle checkpoint , flow cytometry , cyclin b , microbiology and biotechnology , biology , cyclin a , cyclin , cell culture , biochemistry , genetics
Aim . To investigate the role and mechanism of miR-15b in the proliferation and apoptosis of glioma. Methods . The miR-15b mimics were transfected into human glioma cells to upregulate the miR-15b expression. Cyclin D1 was determined by both western blotting analysis and luciferase reporter assay. Methylthiazol tetrazolium (MTT) and flow cytometry were employed to detect the cell proliferation, cell cycle, and apoptosis. Results . Overexpression of miR-15b inhibits proliferation by arrested cell cycle progression and induces apoptosis, possibly by directly targeting Cyclin D1. Both luciferase assay and bioinformatics search revealed a putative target site of miR-15b binding to the 3′-UTR of Cyclin D1. Moreover, expression of miR-15b in glioma tissues was found to be inversely correlated with Cyclin D1 expression. Enforced Cyclin D1 could abrogate the miR-15b-mediated cell cycle arrest and apoptosis. Conclusions . Our findings identified that miR-15b may function as a glioma suppressor by targeting the Cyclin D1, which may provide a novel therapeutic strategy for treatment of glioma.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom